0:00 - 0:12 Intro
_______

Opening Lecture
0:12 - 14:25 What we know and what we don’t know about Sepsis
Manu Shankar-Hari, London/UK
_______

New Data and latest findings
Chair: Didier Payen, Nice/France and Axel Nierhaus, Hamburg/Germany

14:25 - 26:33 Can we improve the microcirculation?
Can Ince, Rotterdam/The Netherlands

26:33 - 38:27 Focus on hemodynamics and shock reversal
Konstanty Szuldrzynski, Warsaw/Poland

38:27 - 48:40 Acute pancreatitis – results from the Pacific trial
Sebastian Rasch, Munich/Germany

______
CytoSorb-Therapy in daily routine
Chair: Claus Krenn, Vienna/Austria and Yatin Mehta, Gurgaon/India

48:40 - 1:02:25 The importance of the right timing and dosing
Steffen Mitzner, Rostock/Germany

1:02:25 - 1:14:49 Liver support on a higher level
János Fazakas, Budapest/Hungary

1:14:49 - 1:25:39 Hemoadsorption with CytoSorb in PICU
Gabriella Bottari, Rome/Italy

______
CytoSorb-Therapy in COVID-19 patients
Chair: Manu Malbrain, Gent/Belgium and Ivano Riva, Bergamo/Italy

1:25:39 - 1:41:40 Latest results from Europe and Asia
Zsolt Molnar, Budapest/Hungary

1:41:40 - 1:52:08 Lessons learned in ECMO-patients
Tae Song, Chicago/USA

Panel discussion – when and how should we use CytoSorb in severely ill COVID-19 patients?
Manu Malbrain, Ivano Riva, Zsolt Molnar, Axel Nierhaus, Konstanty Szuldrzynski